Omalizumab for severe atopic dermatitis in 4- to 19-year-olds: the ADAPT RCT
Article in Efficacy and Mechanism Evaluation (May 2022)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Efficacy and Mechanism Evaluation (May 2022)
Article in International Journal of Pediatrics (October 2021)
Article in Nature Reviews Drug Discovery (August 2021)